GeoVax Labs, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 1955 LAKE PARK DRIVE, SMYRNA, GA,
Mailing Address 1955 LAKE PARK DRIVE, SMYRNA, GA,
Phone 678-384-7220
Fiscal Year End 1231
EIN 870455038
Financial Overview
FY2024
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 11, 2026 | View on SEC |
| 424B5 Prospectus supplement | January 26, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 8-K Current report of material events | December 22, 2025 | View on SEC |
| 424B4 Prospectus for IPO or offering | December 22, 2025 | View on SEC |
| S-1 IPO registration statement | December 12, 2025 | View on SEC |
| 8-K Current report of material events | November 26, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 13, 2025 | View on SEC |
| 8-K Current report of material events | November 13, 2025 | View on SEC |
Material Events
8-K Other January 12, 2026
High Impact
- Helps GeoVax meet Nasdaq listing requirements, crucial for visibility and investor confidence.
- Aims to make the stock more appealing to institutional investors who avoid low-priced stocks.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.